Cargando…

High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging

Endoglin is a 180 kDa transmembrane glycoprotein that was demonstrated to be present in two different endoglin forms, namely membrane endoglin (Eng) and soluble endoglin (sEng). Increased sEng levels in the circulation have been detected in atherosclerosis, arterial hypertension, and type II diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Nejmanová, Iveta, Vitverová, Barbora, Eissazadeh, Samira, Tripská, Katarina, Igreja Sa, Ivone Cristina, Hyšpler, Radomír, Němečkova, Ivana, Pericacho, Miguel, Nachtigal, Petr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703792/
https://www.ncbi.nlm.nih.gov/pubmed/34940528
http://dx.doi.org/10.3390/jcdd8120173
_version_ 1784621549836304384
author Nejmanová, Iveta
Vitverová, Barbora
Eissazadeh, Samira
Tripská, Katarina
Igreja Sa, Ivone Cristina
Hyšpler, Radomír
Němečkova, Ivana
Pericacho, Miguel
Nachtigal, Petr
author_facet Nejmanová, Iveta
Vitverová, Barbora
Eissazadeh, Samira
Tripská, Katarina
Igreja Sa, Ivone Cristina
Hyšpler, Radomír
Němečkova, Ivana
Pericacho, Miguel
Nachtigal, Petr
author_sort Nejmanová, Iveta
collection PubMed
description Endoglin is a 180 kDa transmembrane glycoprotein that was demonstrated to be present in two different endoglin forms, namely membrane endoglin (Eng) and soluble endoglin (sEng). Increased sEng levels in the circulation have been detected in atherosclerosis, arterial hypertension, and type II diabetes mellitus. Moreover, sEng was shown to aggravate endothelial dysfunction when combined with a high-fat diet, suggesting it might be a risk factor for the development of endothelial dysfunction in combination with other risk factors. Therefore, this study hypothesized that high sEng levels exposure for 12 months combined with aging (an essential risk factor of atherosclerosis development) would aggravate vascular function in mouse aorta. Male transgenic mice with high levels of human sEng in plasma (Sol-Eng(+)) and their age-matched male transgenic littermates that do not develop high soluble endoglin (Control) on a chow diet were used. The aging process was initiated to contribute to endothelial dysfunction/atherosclerosis development, and it lasted 12 months. Wire myograph analysis showed impairment contractility in the Sol-Eng(+) group when compared to the control group after KCl and PGF(2)(α) administration. Endothelium-dependent responsiveness to Ach was not significantly different between these groups. Western blot analysis revealed significantly decreased protein expression of Eng, p-eNOS, and ID1 expression in the Sol-Eng(+) group compared to the control group suggesting reduced Eng signaling. In conclusion, we demonstrated for the first time that long-term exposure to high levels of sEng during aging results in alteration of vasoconstriction properties of the aorta, reduced eNOS phosphorylation, decreased Eng expression, and altered Eng signaling. These findings suggest that sEng can be considered a risk factor for the development of vascular dysfunction during aging and a potential therapeutical target for pharmacological intervention.
format Online
Article
Text
id pubmed-8703792
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87037922021-12-25 High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging Nejmanová, Iveta Vitverová, Barbora Eissazadeh, Samira Tripská, Katarina Igreja Sa, Ivone Cristina Hyšpler, Radomír Němečkova, Ivana Pericacho, Miguel Nachtigal, Petr J Cardiovasc Dev Dis Article Endoglin is a 180 kDa transmembrane glycoprotein that was demonstrated to be present in two different endoglin forms, namely membrane endoglin (Eng) and soluble endoglin (sEng). Increased sEng levels in the circulation have been detected in atherosclerosis, arterial hypertension, and type II diabetes mellitus. Moreover, sEng was shown to aggravate endothelial dysfunction when combined with a high-fat diet, suggesting it might be a risk factor for the development of endothelial dysfunction in combination with other risk factors. Therefore, this study hypothesized that high sEng levels exposure for 12 months combined with aging (an essential risk factor of atherosclerosis development) would aggravate vascular function in mouse aorta. Male transgenic mice with high levels of human sEng in plasma (Sol-Eng(+)) and their age-matched male transgenic littermates that do not develop high soluble endoglin (Control) on a chow diet were used. The aging process was initiated to contribute to endothelial dysfunction/atherosclerosis development, and it lasted 12 months. Wire myograph analysis showed impairment contractility in the Sol-Eng(+) group when compared to the control group after KCl and PGF(2)(α) administration. Endothelium-dependent responsiveness to Ach was not significantly different between these groups. Western blot analysis revealed significantly decreased protein expression of Eng, p-eNOS, and ID1 expression in the Sol-Eng(+) group compared to the control group suggesting reduced Eng signaling. In conclusion, we demonstrated for the first time that long-term exposure to high levels of sEng during aging results in alteration of vasoconstriction properties of the aorta, reduced eNOS phosphorylation, decreased Eng expression, and altered Eng signaling. These findings suggest that sEng can be considered a risk factor for the development of vascular dysfunction during aging and a potential therapeutical target for pharmacological intervention. MDPI 2021-12-04 /pmc/articles/PMC8703792/ /pubmed/34940528 http://dx.doi.org/10.3390/jcdd8120173 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nejmanová, Iveta
Vitverová, Barbora
Eissazadeh, Samira
Tripská, Katarina
Igreja Sa, Ivone Cristina
Hyšpler, Radomír
Němečkova, Ivana
Pericacho, Miguel
Nachtigal, Petr
High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging
title High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging
title_full High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging
title_fullStr High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging
title_full_unstemmed High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging
title_short High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging
title_sort high soluble endoglin levels affect aortic vascular function during mice aging
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703792/
https://www.ncbi.nlm.nih.gov/pubmed/34940528
http://dx.doi.org/10.3390/jcdd8120173
work_keys_str_mv AT nejmanovaiveta highsolubleendoglinlevelsaffectaorticvascularfunctionduringmiceaging
AT vitverovabarbora highsolubleendoglinlevelsaffectaorticvascularfunctionduringmiceaging
AT eissazadehsamira highsolubleendoglinlevelsaffectaorticvascularfunctionduringmiceaging
AT tripskakatarina highsolubleendoglinlevelsaffectaorticvascularfunctionduringmiceaging
AT igrejasaivonecristina highsolubleendoglinlevelsaffectaorticvascularfunctionduringmiceaging
AT hysplerradomir highsolubleendoglinlevelsaffectaorticvascularfunctionduringmiceaging
AT nemeckovaivana highsolubleendoglinlevelsaffectaorticvascularfunctionduringmiceaging
AT pericachomiguel highsolubleendoglinlevelsaffectaorticvascularfunctionduringmiceaging
AT nachtigalpetr highsolubleendoglinlevelsaffectaorticvascularfunctionduringmiceaging